• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PAA 5.88% 18.0¢

PHARMAUST LIMITED

PharmAust is a clinical-stage biotechnology company developing new therapeutics for human... PharmAust is a clinical-stage biotechnology company developing new therapeutics for human health. The Company's segments include Corporate and Research. The Company is focused on repurposing monepantel for the treatment of neurodegenerative diseases, in particular amyotrophic lateral sclerosis (ALS) - the most common form of motor neurone disease (MND). The Company's lead candidate, Monepantel (MPL), is a potent and safe inhibitor of the mTOR pathway which plays a central role in cell growth and proliferation and in degenerating neurons. The mTOR pathway regulates the cellular “cleaning process”, where toxic protein is broken down into macromolecules to be reused. This autophagic process is disrupted in most neurodegenerative diseases, including motor neurone disease. The company successfully completed a Phase 1 study in monepantel as a treatment for ALS/MND with encouraging results. Monepantel has subsequently been accepted into the prestigious HEALEY ALS Platform Trial in the US. The company anticipates starting the Phase 2/3 study in H2 2024.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
PAA
Phase II Begins, Cashed Up with Healey In the Sights of Big Pharma $$$
5 6 7
14:03 377 102K
14:03 Last post  Peeteepoo Comments Created with Sketch.  377  Views Created with Sketch.  102K 
PAA
Pharmaust - Media & News
2 3
20/09/24 133 49K
20/09/24 Last post  Quiltman Comments Created with Sketch.  133  Views Created with Sketch.  49K 
PAA 19/09/24 16 5.0K
19/09/24 Last post  Dryasachip Comments Created with Sketch.  16  Views Created with Sketch.  5.0K 
PAA 17/09/24 97 27K
17/09/24 Last post  Greenfly Comments Created with Sketch.  97  Views Created with Sketch.  27K 
PAA
PAA - General discussions
2
11/09/24 102 32K
11/09/24 Last post  Satishbh Comments Created with Sketch.  102  Views Created with Sketch.  32K 
PAA
Sale of Pela Resources back in 2012
10/09/24 8 7.5K
10/09/24 Last post  RAN58 Comments Created with Sketch.  8  Views Created with Sketch.  7.5K 
PAA
Walk to Defeat MND
08/09/24 40 12K
08/09/24 Last post  Densy Comments Created with Sketch.  40  Views Created with Sketch.  12K 
PAA 08/09/24 7 2.1K
08/09/24 Last post  NZ Trader Comments Created with Sketch.  7  Views Created with Sketch.  2.1K 

See All Discussions arrow Created with Sketch.

Timeline

EMA pre-submission meeting paves the way for OMPD Request
17 Sep 08:47
 
Proposed issue of securities - PAA
05 Sep 09:25
 
Notice of Annual General Meeting/Proxy Form
05 Sep 08:36
 
Section 708A Cleansing Statement
02 Sep 14:42
 
Application for quotation of securities - PAA
02 Sep 14:38
 
Change of AGM Date
02 Sep 11:35
 
View More arrow Created with Sketch.
(20min delay)
Last
18.0¢
Change
0.010(5.88%)
Mkt cap ! $87.55M
Open High Low Value Volume
17.0¢ 18.0¢ 17.0¢ $36.1K 210.8K

Buyers (Bids)

No. Vol. Price($)
1 58823 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 154996 3
View Market Depth
Last trade - 16.10pm 20/09/2024 (20 minute delay) ?
Last
17.0¢
  Change
0.010 ( 1.49 %)
Open High Low Volume
16.5¢ 17.5¢ 16.5¢ 246876
Last updated 15.23pm 20/09/2024 ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.